HUP0402674A2 - Egy vagy több szteroidot, egy vagy több tetrahidrofolát komponenst és B12 vitamint tartalmazó gyógyszerkészítmények - Google Patents

Egy vagy több szteroidot, egy vagy több tetrahidrofolát komponenst és B12 vitamint tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0402674A2
HUP0402674A2 HU0402674A HUP0402674A HUP0402674A2 HU P0402674 A2 HUP0402674 A2 HU P0402674A2 HU 0402674 A HU0402674 A HU 0402674A HU P0402674 A HUP0402674 A HU P0402674A HU P0402674 A2 HUP0402674 A2 HU P0402674A2
Authority
HU
Hungary
Prior art keywords
tetrahydrofolic acid
vitamin
steroids
tetrahydrofolic
pharmaceutical compositions
Prior art date
Application number
HU0402674A
Other languages
English (en)
Inventor
Herman Jan Tijmen Coelingh Bennink
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of HUP0402674A2 publication Critical patent/HUP0402674A2/hu
Publication of HUP0402674A3 publication Critical patent/HUP0402674A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135Compounds containing heavy metals
    • A61K31/714Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

A találmány nőivarú emlősök hormonális fogamzásgátlásához éshormonpótló terápiájához használható gyógyszerkészletre vonatkozik. Anevezett készlet legalább 10 orális dózisegységből áll, melydózisegység az ösztrogének és progesztogének közül kiválasztott,legalább 1 <g mennyiségben levő egy vagy több szteroidot; a (6S)-tetrahidrofolsav, 5-metil-(6S)-tetrahidrofolsav, 5-formil-(6S)-tetrahidrofolsav, 10-formil-(6R)-tetrahidrofolsav, 5,10-metilén-(6R)-tetrahidrofolsav, 5,10-metenil-(6R)-tetrahidrofolsav, 5-formimino-(6S)-tetrahidrofolsav, ezen tetrahidrofolsavak gyógyszerészetilegalkalmazható sói és glutamilszármazékai közül kiválasztott, legalább0,1 mg mennyiségben levő egy vagy több tetrahidrofolát alkotórészt éslegalább 0,1 mg B12 vitamint tartalmaz. Ó
HU0402674A 2002-02-21 2002-11-15 Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin b12 HUP0402674A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075695 2002-02-21
PCT/NL2002/000741 WO2003070255A1 (en) 2002-02-21 2002-11-15 Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin b12

Publications (2)

Publication Number Publication Date
HUP0402674A2 true HUP0402674A2 (hu) 2005-04-28
HUP0402674A3 HUP0402674A3 (en) 2012-12-28

Family

ID=27741182

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402674A HUP0402674A3 (en) 2002-02-21 2002-11-15 Pharmaceutical compositions comprising one or more steroids one or more tetrahydrofolate components and vitamin b12

Country Status (29)

Country Link
US (1) US20050164977A1 (hu)
EP (1) EP1478373B1 (hu)
JP (1) JP5037779B2 (hu)
KR (1) KR100936827B1 (hu)
CN (1) CN1620302B (hu)
AT (1) ATE341333T1 (hu)
AU (1) AU2002343249B2 (hu)
BR (1) BR0215613A (hu)
CA (1) CA2476940C (hu)
CR (1) CR7420A (hu)
CY (1) CY1106273T1 (hu)
DE (1) DE60215224T2 (hu)
DK (1) DK1478373T3 (hu)
EA (1) EA007599B1 (hu)
EC (1) ECSP045305A (hu)
ES (1) ES2274107T3 (hu)
HK (1) HK1078780A1 (hu)
HU (1) HUP0402674A3 (hu)
IL (2) IL163579A0 (hu)
ME (1) MEP37208A (hu)
MX (1) MXPA04008185A (hu)
NO (1) NO20043932L (hu)
NZ (1) NZ534806A (hu)
PL (1) PL209558B1 (hu)
PT (1) PT1478373E (hu)
RS (1) RS50909B (hu)
UA (1) UA80965C2 (hu)
WO (1) WO2003070255A1 (hu)
ZA (1) ZA200407545B (hu)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005023301B4 (de) * 2005-05-13 2012-05-31 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Zusammensetzung enthaltend Gestagene und/oder Estrogene und 5-Methyl-(6S)-tetrahydrofolat
US20060293295A1 (en) * 2005-05-13 2006-12-28 Kai Strothmann Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl- (6S)-tetrahydrofolate
UY29527A1 (es) 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
AU2012227235B2 (en) * 2005-05-13 2015-06-11 Bayer Intellectual Property Gmbh Pharmaceutical composition comprising progestogens and/or estrogens and 5-methyl-(6S)-tetrahydrofolate
AU2013202756B2 (en) * 2006-07-06 2015-06-04 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
CN101489563A (zh) * 2006-07-06 2009-07-22 拜耳先灵医药股份有限公司 用于避孕和预防先天性畸形风险的药物制剂
JP2009542588A (ja) * 2006-07-06 2009-12-03 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 避妊及び先天的異常の危険性の予防のための医薬製剤
US8617597B2 (en) * 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
EP1891959A1 (de) * 2006-08-14 2008-02-27 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Zusammensetzung zur Kontrazeption und zur Verminderung des Risikos angeborener Fehlbildungen
GB0715502D0 (en) * 2007-08-08 2007-09-19 Univ Manchester Methods
CN101945646A (zh) * 2008-02-13 2011-01-12 拜耳先灵医药股份有限公司 含雌二醇的药物递送系统
UY32836A (es) 2009-08-12 2011-03-31 Bayer Schering Pharma Ag Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato
PL2324832T5 (pl) * 2009-11-09 2017-10-31 Biogena Naturprodukte Gmbh & Co Kg Suplement diety przy przyjmowaniu hormonalnych środków antykoncepcyjnych
CA2835979C (en) 2011-06-01 2018-05-01 Estetra S.A. Process for the production of estetrol intermediates
PL2714710T3 (pl) 2011-06-01 2017-03-31 Estetra S.P.R.L. Sposób wytwarzania estetrolowych związków pośrednich
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
ES2925534T3 (es) * 2011-11-05 2022-10-18 South Alabama Medical Science Found Métodos, formulaciones y kits para reponer rápidamente los niveles de folato en mujeres
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
MX369035B (es) * 2013-12-12 2019-10-25 Donesta Bioscience B V Unidad de dosificacion solida de disolucion oral que contiene un componente de estetrol.
RU2016143081A (ru) 2014-05-22 2018-06-26 Терапьютиксмд, Инк. Натуральные комбинированные гормонозаместительные составы и терапии
ME03728B (me) 2015-06-18 2021-01-20 Estetra Sprl Orodisperzibilna dozna jedinica koja sadrži komponentu estetrola
RS61777B1 (sr) 2015-06-18 2021-06-30 Estetra Sprl Oralno-disperzibilna tableta koja sadrži estetrol
SI3310345T1 (sl) 2015-06-18 2021-05-31 Estetra Sprl Orodisperzibilna tableta, ki vsebuje estetrol
MY195019A (en) 2015-06-18 2023-01-03 Estetra Sprl Orodispersible dosage unit containing an estetrol component
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9931349B2 (en) 2016-04-01 2018-04-03 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR20220144885A (ko) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT877563E (pt) * 1996-01-31 2004-08-31 Univ South Alabama Preparacoes alimentares e vitaminicas contendo o isomero natural de folatos reduzidos
CA2261764A1 (en) * 1996-07-30 1998-02-05 Jeffrey B. Blumberg Dietary supplements
WO1998011900A2 (en) * 1996-09-18 1998-03-26 Sarill William J Compositions containing cobalamin and amino acids
US6220453B1 (en) * 1998-04-07 2001-04-24 Fuji Photo Film Co., Ltd. Blood filter unit
EP2002839A1 (en) * 1998-04-17 2008-12-17 Ortho McNeil Pharmaceutical, Inc. Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
WO1999065337A1 (en) * 1998-06-19 1999-12-23 Beth Israel Deaconess Medical Center Dietary supplement for post-menopausal women
US6479545B1 (en) * 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
DE10022510A1 (de) * 2000-05-10 2001-11-15 Basf Ag Zusammensetzungen enthaltend Folsäure und reduziertes Folat
BG104880A (en) * 2000-10-24 2002-04-30 Иван ХРИСТОВ Medicamentous preparation for multiple sclerosis treatment

Also Published As

Publication number Publication date
CA2476940A1 (en) 2003-08-28
ECSP045305A (es) 2004-10-26
KR100936827B1 (ko) 2010-01-14
RS50909B (sr) 2010-08-31
CA2476940C (en) 2011-11-01
CN1620302A (zh) 2005-05-25
DE60215224T2 (de) 2007-08-23
RS73304A (en) 2007-02-05
US20050164977A1 (en) 2005-07-28
PT1478373E (pt) 2007-01-31
ATE341333T1 (de) 2006-10-15
DK1478373T3 (da) 2007-01-15
JP2005523283A (ja) 2005-08-04
PL371441A1 (en) 2005-06-13
ZA200407545B (en) 2006-06-28
DE60215224D1 (de) 2006-11-16
JP5037779B2 (ja) 2012-10-03
PL209558B1 (pl) 2011-09-30
MEP37208A (en) 2011-02-10
EA007599B1 (ru) 2006-12-29
HK1078780A1 (en) 2006-03-24
HUP0402674A3 (en) 2012-12-28
CR7420A (es) 2006-02-06
NO20043932L (no) 2004-11-19
NZ534806A (en) 2006-05-26
IL163579A0 (en) 2005-12-18
MXPA04008185A (es) 2004-11-26
EA200401014A1 (ru) 2006-10-27
EP1478373B1 (en) 2006-10-04
WO2003070255A1 (en) 2003-08-28
BR0215613A (pt) 2004-12-07
UA80965C2 (en) 2007-11-26
ES2274107T3 (es) 2007-05-16
EP1478373A1 (en) 2004-11-24
CY1106273T1 (el) 2011-10-12
KR20040094711A (ko) 2004-11-10
AU2002343249A1 (en) 2003-09-09
AU2002343249B2 (en) 2009-02-05
IL163579A (en) 2011-03-31
CN1620302B (zh) 2011-04-27

Similar Documents

Publication Publication Date Title
HUP0402674A2 (hu) Egy vagy több szteroidot, egy vagy több tetrahidrofolát komponenst és B12 vitamint tartalmazó gyógyszerkészítmények
CL2009002187A1 (es) Composicion farmaceutica anticonceptiva que comprende 5-metil-(6s)-tetrahidrofolato, estrogenos y/o progestagenos, opcionalmente vitamina b6 y/o vitamina b2 y coadyuvantes/vehiculos; kit; proceso para prepararla; uso para reducir el riesgo de enfermedades y malformaciones congenitas por carencia de folato (div. sol. 1130-06).
ES2376472T3 (es) Utilización de tetrahidrofolatos para la influencia sobre el nivel de homociste�?na.
CN101489563A (zh) 用于避孕和预防先天性畸形风险的药物制剂
WO2006099233B1 (en) Compositions and methods for the treatment of osteoporosis and inflammatory joint disease
WO1999053910A3 (en) Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
RU98111617A (ru) Применение тетрагидрофолатов естественной стереоизомерной формы при получении фармацевтической композиции, предназначенной для воздействия на уровень гомоцистеина, в частности для поддержания процесса реметилирования гомоцистеина
CA2477101A1 (en) Use of folates for preventing and treating inflammation and diseases associated with inflammation
WO2008003363A1 (de) Pharmazeutische zubereitung zur kontrazeption und zur verminderung des risikos angeborener fehlbildungen
JP2009514776A5 (hu)
JP2004538262A5 (hu)
WO2002083151A2 (en) Compositions and methods for treating an arthritic condition
AU2001297789A1 (en) Compositions and methods for treating an arthritic condition
TH105386A (th) องค์ประกอบทางเภสัชกรรมซึ่งประกอบรวมด้วยโปรเจสโตเจน และ/หรือ เอสโตรเจน และ 5-เมธิล-(6s)-เททระไฮโดรโฟเลต
HU9900213D0 (en) Pharmaceutical compositions for diminishing side-effects of hormone-containing compositions
EP1891959A1 (de) Pharmazeutische Zusammensetzung zur Kontrazeption und zur Verminderung des Risikos angeborener Fehlbildungen
TH105386B (th) องค์ประกอบทางเภสัชกรรมซึ่งประกอบรวมด้วยโปรเจสโตเจน และ/หรือ เอสโตรเจน และ 5-เมธิล-(6s)-เททระไฮโดรโฟเลต

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE

Free format text: FORMER OWNER(S): SCHERING AKTIENGESELLSCHAFT, DE

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished